2 Asthma, COPD, and Hiccups Flashcards

1
Q

Mild asthma

A

s/s: dyspnea only with activity
initial PEF β‰₯70% predicted or personal best
cc: prompt relief with inhaled SABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Moderate asthma

A

s/s: dyspnea interferes with or limits usual activity
initial PEF 40-69 predicted or personal best
cc: relief from frequent inhaled SABA. Symptoms for 1-2 days after oral corticosteroids begun

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Severe asthma

A

s/s: dyspnea at rest; interferes with conversation
initial PEF **<40% predicted or personal best
cc: partial relief from frequent inhaled SABA. Symptoms for β‰₯3 days after oral corticosteroids begun

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Life-threatening asthma

A

ss: too dyspneic to speak; perspiring 😰
initial PEF ≀25% predicted or personal best
cc: minimal or no relief from frequent inhaled SABA;
IV steroids; adjunctive therapy; needs ED or ICU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rirsk factors for death from asthma

A

past history of severe exacerbation
β‰₯2 hospitalizations for asthma in the past year
β‰₯3 canisters per month of inhaled SABA
β‰₯4 ED visits for asthma in the past year

difficulty perceiving airflow obstrution or its severity
low SE status or inner-city resident
illicit drug use
psychiatric disease or medical comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Heart failure can largely be excluded in patients with acute dyspnea and NTproBNP of

A

NT-pro-BNP ≀300 pg/mL
| BNP <100 pg/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

only drug that’s US FDA approved for intractable hiccups

A

Chlorpromazine
initial dose in ED:
25-50 mg IV, repeat in 2-4 h if needed

maintenance dose on discharge
25-50 mg PO 3-4x/day

  • benign and self-limited hiccups: <48 hours
  • persistent: >48 hours
  • intractable - last longer than a month
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other drugs for hiccups

A

Metoclopramide 10 mg IV or IM
MD: 10-20 mg PO 3x/day for 10 days

Haloperidol 2-5 mg IM
MD: 2-4 mg PO 3x/day

Nifedipine 10-20 mg PO
MD: 10-20 mg PO 3-4x/day

Gabapentin 100 mg
MD: 100 mg PO 3x/day, titrated up to 120 mg/day (?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Physical maneuvers as management for hiccups

A

FIQS

Foreign body removal
Ice water, sip
Quickly drink water
Sugar, swallow a teaspoon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Classification of COPD severity

A

mild: FEV1 β‰₯80% pred
mod: FEV1 50-79%
SEV: FEV1 30-49%
very sev: FEV1 <30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Target SpO2 for COPD patients

A

88-92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Doses of magnesium sulfate for status asthmaticus

A

1-2g IV over 30 minutes

Nebulization:
95 mg of nebulized MgSO4 in 4 divided doses 20mins apart
384 mg of nebulized MgSO4 in sterile water (?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Other drugs for status asthmaticus

A

KETAMINE
IV bolus dose of 0.15 mg/kg
then infusion of 0.25 mg/kg/hour

EPINEPHRINE
SC or IM, 0.5 mg (standard adult EpiPen dose) πŸ“Œ

HeliOx
80% helium, 20% oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inclusions for NIV

A

Acidosis <7.36
Hypercapnea, PaCO2 >50 mmHg
Oxygen deficit, PaO2 <60 mmHg or SaO2 <90%
Severe dyspnea with clinical signs such as respiratory muscle fatigue or increased work of breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Exclusions for NIV

A

Respiratory arrest
High aspiration risk
Viscous or copious secretions

CV instability
Burns
Change in mental status; uncooperative patient

Recent facial or gastroesophageal surgery
Craniofacial trauma
Fixed nasopharyngeal abnoramalities
Extreme obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for intubation

A

Respiratory or cardiac arrest
Respiratory failure
Persistent hypoxemia despite optimal respiratory treatment
Unable to tolerate NIV or NIV failure

Massive aspiration
Persistent inability to remove respiratory secretions

Hemodynamic instability
Hypotension

Decreased consciousness
or increased agitation